 |
Over 3000 patients have been treated at the Neutron Therapy Facility (NTF) since it opened on September 7, 1976.
Neutrons are more effective at killing tumors than conventional radiation therapy. Cure rate depends on the type of cells in the tumor (histology), the size of the tumor (stage and/or grade), whether the tumor has spread to other parts of the body (metastasis), and the patient's general health.
Neutrons may be appropriate for the following sites, depending on stage and histology.
| HEAD AND NECK | Salivary glands, tongue, pharynx, oral cavity, nasopharynx, brain tumors |
| CHEST | Localized tumors of lung, mediastinum, pleura, pericardium |
| ABDOMEN | Pancreas, colon, bile duct, gallbladder, ampula of vater, peritoneum |
| PELVIS | Prostate, bladder, uterus, rectosigmoid |
| EXTREMITIES AND TRUNK | Soft tissue, bone, cartilage |
| PALLIATIVE | Large tumors and metastasis from neutron-sensitive tumors |
| SKIN | Melanoma |
|
|
|
 |
| NTF NEWS |
|
On December 6, 2004 we officially reopened as the NIU Institute for Neutron Therapy at Fermilab. For more information, see www.neutrontherapy.niu.edu.
Dr Arlene Lennox, Medical Physicist at the Neutron Therapy Facility gave a lecture at the Fermilab Lecture Series on "Hadron Therapy and Cancer Treatment". A link to the slides can be found on our Publications page.
To view television news features about the Neutron Therapy Facility, see our Publications page.
A Georgia Tech graduate student, Jeremy Sweezy, recently received his PhD for research in brain tumor therapy using fast neutrons.
We have published a paper describing the use of microcurrent therapy to treat side effects of radiation therapy. See our Publications page for more information.
|
|
|
|
|
|
